Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
<p>Abstract</p> <p>Background</p> <p>The management of unresectable or metastatic gastrointestinal stromal tumors (GISTs) has previously been difficult as they are resistant to conventional chemotherapy and radiation. The development of imatinib mesylate has made a majo...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/4/74 |